Clinical Trials Browser

Phase 2/3 × Esophageal Squamous Cell Carcinoma × Paclitaxel × Clear all

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Phase 2/3 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma